Evidence That Aβ42 Plasma Levels in Presenilin-1 Mutation Carriers Do not Allow for Prediction of Their Clinical Phenotype

This publication has 38 references indexed in Scilit:

• Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease
  Archives of Neurology, 1999
• Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein
  Neurobiology of Disease, 1998
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
  Nature, 1998
• Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease
  Human Molecular Genetics, 1998
• Presenilin mutations in Alzheimer's disease
  Human Mutation, 1998
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
  Nature Medicine, 1997
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
  Neuron, 1996
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
  Nature, 1996
• Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3
  Human Molecular Genetics, 1995
• The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families
  Nature Genetics, 1995